IDRA - Idera Pharmaceuticals, Inc.
Close
0.425
-0.117 -27.506%
Share volume: 0
Last Updated: Tue 17 Jan 2023 10:00:01 PM CET
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$0.54
-0.12
-21.57%
Summary score
34%
Profitability
40%
Dept financing
25%
Liquidity
38%
Performance
30%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-328%
Return on assets
-19.38%
Return on sales
-792.2%
Return on invested capital
187.6%
Total debt ratio
44.55%
Debt ratio change over timeo
-1.23%
Current Ratio
7.74%
Quick Ratio
0%
Cash Position Ratio
6.45%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-1254.93%
Return on assets
-26.62%
Return on sales
0%
Return on invested capital
202.02%
Total debt ratio
143.77%
Debt ratio change over timeo
-1.92%
Current Ratio
2.74%
Quick Ratio
0%
Cash Position Ratio
2.13%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
63.36%
Return on assets
-23.14%
Return on sales
0%
Return on invested capital
360.18%
Total debt ratio
200.3%
Debt ratio change over time
-0.47%
Current Ratio
4.59%
Quick Ratio
0%
Cash Position Ratio
3.28%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-481.31%
Return on assets
-95.78%
Return on sales
-524.11%
Return on invested capital
-293.2%
Total debt ratio
-122.77%
Debt ratio change over time
-1.23%
Current Ratio
-6.13%
Quick Ratio
0%
Cash Position Ratio
-5.82%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | IDRA | SGEN | NK | SRNG |
---|---|---|---|---|
Return on equity | -328% | -2.55% | -11.93% | 0% |
Return on assets | -19.38% | -3.03% | -10.33% | 0% |
Return on sales | -792.2% | -31.63% | 0% | 0% |
Return on invested capital | 187.6% | 271.68% | -26.98% | 0% |
Profitability | 17% | 25% | 25% | 50% |
Total debt ratio | 44.55% | 18.39% | 14.82% | 0% |
Debt ratio change over time | -1.23% | -2.02% | -1.56% | 0% |
Dept financing | 25% | 10% | 8% | 25% |
Current Ratio | 2.74% | 4.35% | 4.89% | 0% |
Quick Ratio | 0% | 4.07% | 0% | 0% |
Cash Position Ratio | 2.13% | 1% | 2.85% | 0% |
Liquididy | 50% | 41% | 26% | 0% |
Short-term ratios | IDRA | SGEN | NK | SRNG |
---|---|---|---|---|
Return on equity | -1254.93% | 4.71% | -14.24% | 0% |
Return on assets | -26.62% | 2.45% | -12.07% | 0% |
Return on sales | 0% | -8.71% | 0% | 0% |
Return on invested capital | 202.02% | 58.34% | -26.3% | 0% |
Profitability | 50% | 57% | 0% | 0% |
Total debt ratio | 143.77% | 17.89% | 16.14% | 0% |
Debt ratio change over time | -1.92% | -1.88% | -1.73% | 0% |
Dept financing | 25% | 3% | 3% | 25% |
Current Ratio | 2.74% | 4.35% | 4.89% | 0% |
Quick Ratio | 0% | 4.07% | 0% | 0% |
Cash Position Ratio | 2.13% | 1% | 2.85% | 0% |
Liquididy | 33% | 56% | 50% | 0% |